Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS.

By Kuo-Yi Yang, Lei-Chwen Lin, Ting-yu Tseng, Shauchun Wang, T. Tsai. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2007

604 citations recorded by the source corpus.

Subfields: Molecular Biology, Molecular Medicine, Pharmacology

View Paper: https://www.semanticscholar.org/paper/7fdb9afa5b19dca76772528db05e573b3ea404b2

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. Raymond Schiffelers
2. W. E. Hennink
3. S. Okonogi
4. Ornchuma Naksuriya

In Molecular Medicine

1. Raymond Schiffelers
2. W. E. Hennink
3. S. Okonogi
4. Ornchuma Naksuriya

Citations in the corpus

• Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment. (2014, background): “01 mg/ml, indicating that oral bioavailability was only 1% [37].”
• Bioactivity of dietary polyphenols: The role of metabolites (2020, background): “The low uptake of curcumin administered p.o. was confirmed in laboratory rats, when oral bioavailability of the polyphenol was found to be lower than 1% (Asai and Miyazawa 2000; Yang et al. 2007).”